WESTPORT, Feb 18 (Reuters Health) - All women with breast
cancer who are younger than 35 years should be considered for
adjuvant >cytotoxic treatment, even when the cancer is considered to be
low risk. > >Researchers reporting in the February 19th issue of the
British Medical Journal say that the recommendation is based on a
study >results indicating that women younger than 35 with low-risk breast
cancer who do not receive chemotherapy have a significantly >higher
mortality rate than similarly treated older women. > > http://www.cancereducation.com/CancerSysPages/Reuters/ViewArticle.cfm?Articl e=Cancer/cl02180a.htm >
